Signal function measurement
Data collection
Signal function performance, as defined in the EmONC signal functions’ operational definitions table, is assessed by interviewing staff, and by looking at facility registers (and individual patient records if needed) to determine whether each individual signal function was performed at least once in the previous three-month period and if a complication requiring each signal function was reported in the register (confirming the plausibility that the signal function was performed in the previous three months). A three-month reference period for measuring the performance of the signal functions is recommended, based on the principle that skills must be performed with some frequency in order to maintain competence and confidence as well as to minimize concerns about longer recall periods.
The performance of EmONC signal functions is ideally recorded at the end of every quarter using EmONC signal function checklists, such as the ones below in Figure 1. Some countries may choose to monitor signal function performance more frequently (e.g., monthly) as part of their HMIS or a paper-based programme monitoring system. For routine programme monitoring (e.g., monthly and quarterly), facilities could assess their own performance of the signal functions. Typically, the facility in-charge or unit heads (e.g., maternity unit, SNCU) would be responsible for determining signal function performance. Periodically (e.g., annually and every 3-5 years), a team external to the facility (e.g., sub-national managers, national evaluators, supervisors/mentors, local research firm) could review facilities’ self-reports as well as conduct their own assessment of signal function performance for the three months prior to their assessment visit.
Figure 1: EmONC signal function checklists
Basic EmONC Signal Functions | Performed | Not performed |
---|---|---|
OBSTETRIC | ||
Administer medications to treat postpartum hemorrhage | ||
Administer parenteral antibiotics (woman) | ||
Administer magnesium sulfate | ||
Remove retained products of conception | ||
Perform manual removal of placenta | ||
Perform assisted vaginal birth | ||
Provide IV fluid replacement therapy (woman) | ||
NEONATAL | ||
Perform newborn resuscitation with bag and mask | ||
Initiate and support early and exclusive breastfeeding | ||
Administer parenteral antibiotics (newborn) | ||
Practice immediate kangaroo mother care for preterm and LBW infants | ||
Provide thermal care with radiant warmer or incubator (newborn) | ||
Administer oxygen therapy with pulse oximetry for stabilization and transportation (newborn) | ||
REFERRAL | ||
Arrange ambulance, with trained and equipped provider, to a facility that can provide definitive care (woman and/or newborn) |
Comprehensive EmONC Signal Functions | Performed | Not performed |
---|---|---|
OBSTETRIC | ||
Administer medications to treat postpartum hemorrhage | ||
Administer parenteral antibiotics (woman) | ||
Administer magnesium sulfate | ||
Remove retained products of conception | ||
Perform manual removal of placenta | ||
Perform assisted vaginal birth | ||
Provide IV fluid replacement therapy (woman) | ||
Administer antenatal corticosteroids | ||
Perform cesarean section | ||
Perform blood transfusion (woman) | ||
NEONATAL | ||
Perform newborn resuscitation with bag and mask | ||
Initiate and support early and exclusive breastfeeding | ||
Administer parenteral antibiotics (newborn) | ||
Practice immediate kangaroo mother care for preterm and LBW infants | ||
Provide thermal care with radiant warmer or incubator (newborn) | ||
Administer oxygen therapy with pulse oximetry (newborn) | ||
Provide CPAP (newborn) | ||
Provide phototherapy (newborn) | ||
Perform blood transfusion (newborn) | ||
Enable assisted feeding with expressed breast milk with cup and spoon and tube feeding | ||
Provide IV fluids (newborn) |
Intensive EmONC Signal Functions | Performed | Not performed |
---|---|---|
OBSTETRIC | ||
Administer medications to treat postpartum hemorrhage | ||
Administer parenteral antibiotics (woman) | ||
Administer magnesium sulfate | ||
Remove retained products of conception | ||
Perform manual removal of placenta | ||
Perform assisted vaginal birth | ||
Provide IV fluid replacement therapy (woman) | ||
Administer antenatal corticosteroids | ||
Perform cesarean section | ||
Perform blood transfusion (woman) | ||
Perform intensivate level organ support (woman) | ||
NEONATAL | ||
Perform newborn resuscitation with bag and mask | ||
Initiate and support early and exclusive breastfeeding | ||
Administer parenteral antibiotics (newborn) | ||
Practice immediate kangaroo mother care for preterm and LBW infants | ||
Provide thermal care with radiant warmer or incubator (newborn) | ||
Administer oxygen therapy with pulse oximetry (newborn) | ||
Provide CPAP (newborn) | ||
Provide phototherapy (newborn) | ||
Perform blood transfusion (newborn) | ||
Enable assisted feeding with expressed breast milk with cup and spoon and tube feeding | ||
Provide IV fluids (newborn) | ||
Perform mechanical ventilation (newborn) | ||
Perform screening and treatment for retinopathy of prematurity (newborn) |
Note that the referral signal function (arrange ambulance, with trained and equipped provider, to a facility that can provide definitive care) is only required at the Basic EmONC level.1
EmONC classification
Once signal function performance has been recorded, a facility is classified for the three-month period as a Basic EmONC facility, Comprehensive EmONC facility, or Intensive EmONC facility if all of the signal functions for that level of EmONC were carried out.
It may also be helpful to know how many facilities are close to being classified as EmONC, missing only 1 or 2 signal functions. For example, the following classifications can be used:
- BEmONC -1,-2 describes a facility that performs all but one or two of the BEmONC signal functions.
- CEmONC -1,-2 describes a facility that performs all but one or two of the CEmONC signal functions.
- IEmONC -1,-2 describes a facility that performs all but one or two of the IEmONC signal functions.
- Facilities missing more than two signal functions can be described as not yet EmONC.
The number of facilities by EmONC performance classification can then be counted and summarized as follows:
Total No. Facilities Assessed | No. BEmONC (a) | No. CEmONC (b) | No. IEmONC (c) | Total No. EmONC (a+b+c) | No. BEmONC -1 and -2 (d) | No. CEmONC -1 and -2 (e) | No. IEmONC -1 and -2 (f) | Total No. Missing 1 or 2 SFs (d+e+f) | No. Not Yet EmONC (g) |
---|---|---|---|---|---|---|---|---|---|
The classifications above are based solely on signal function performance and do not take into consideration at what level a facility is expected to be functioning. Once a designated set of EmONC facilities has been selected by country planners (see ‘Step-by-step implementation’), it is also possible to categorize facilities based on whether they are performing all the signal functions they are expected to perform. The table below shows various combinations of designation vs. performance levels.
Designated to be… | ||||
---|---|---|---|---|
BEmONC | CEmONC | IEmONC | ||
Performing as… | Not yet EmONC | Lower | Lower | Lower |
BEmONC | On target | Lower | Lower | |
CEmONC | Higher | On target | Lower | |
IEmONC | N/A | Higher | On target |
On target
denotes facilities that are performing at the level they are intended to.Lower
denotes facilities that are performing at a level lower than they are intended to.Higher
denotes facilities that are performing at a higher level than they are intended to. (These facilities should be redesignated to the level at which they are performing.)
In addition to performing these analyses for the full set of EmONC signal functions, it may also be useful to look at obstetric and newborn signal functions separately. For example, the following classifications could be used:
No. Signal Functions Performed | Final Classification | ||
---|---|---|---|
Obstetric signal functions | Neonatal signal functions | ||
Designated BEmONC | All | All | BEmONC |
All | Not all | BEmONC for obstetric but not yet neonatal | |
Not all | All | BEmONC for neonatal but not yet obstetric | |
Not all | Not all | Not yet BEmONC | |
Designated CEmONC | All | All | CEmONC |
All | Not all | CEmONC for obstetric but not yet neonatal | |
Not all | All | CEmONC for neonatal but not yet obstetric | |
Not all | Not all | Not yet CEmONC | |
Designated IEmONC | All | All | IEmONC |
All | Not all | IEmONC for obstetric but not yet neonatal | |
Not all | All | IEmONC for neonatal but not yet obstetric | |
Not all | Not all | Not yet IEmONC |
Analysis and interpretation
The number of facilities that are classified as EmONC is used to calculate Indicator 1a and Indicator 1b. The EmONC classification of facilities can also be used as a variable to disaggregate all other indicators in the EmONC Framework (e.g., institutional delivery rate in facilities classified as EmONC vs. institutional delivery rate in facilities that are not yet EmONC).
Analysis of individual signal function performance, or lack of performance, can also be used to plan and monitor implementation and change over time. These data can be presented in terms of the proportion of facilities providing each of the signal functions, and can be disaggregated by level of facility, managing authority (public vs. private) and sub-national area. For example, if it is determined that a specific signal function has been chronically missing from a large number of facilities, planners and implementers can study why that signal function is not being performed.
Common reasons for non-performance of a signal function include:
- The complication arose, but:
- There were problems with infrastructure (e.g., operating theater not functional)
- Drugs/supplies/equipment were missing – problems related to procurement, distribution, and/or maintenance
- Health provider cadres working at the facility are not authorized to perform the signal function
- Skilled health personnel require further training/coaching/mentoring to be competent and confident
- Additional skilled personnel/specific cadres with EmONC capacity are needed
- Facility, sub-national or national policies present barriers to the provision of care such as clinical interventions being absent from national treatment protocols, restrictive authorization of health provider cadres to perform certain signal functions, norms regarding what services are performed at what level, or deficits in pre-service curricula
- The complication did not arise within the time period due to:
- Excellent routine and preventative care
- Low caseload
Low caseload can be due to a number of factors and could be investigated by determining: whether the catchment population is too small given the incidence of the complication in question; if access is a serious problem for reasons related to information, cost, distance, transport or cultural practices; or if bypassing this facility for another, better-functioning facility is common practice.
Signal function performance can fluctuate from one quarter to the next for various reasons. For example, key personnel can be transferred; stock outs or supply chain failures can occur; and caseloads can drop because of a disease outbreak. Yet the sustained performance of all of the EmONC signal functions is the goal and routine monitoring can support that end by flagging potential problems for quick resolution, such as making adjustments to the workforce, addressing stockouts or repairing equipment. Triangulating with indicators such as “Health Workforce Adequate for Caseload,” or “Equipment, Drugs and Supplies” may help identify causes for non-performance to guide corrective efforts. Additional examination of health system elements that are not captured by the EmONC Framework (e.g., supportive supervision or continuing medical education) may also be required to identify problems (see example of assisted vaginal birth at the Basic EmONC level in Box 1).
All facilities should be prepared to transfer a patient if needed. Although Comprehensive and Intensive EmONC facilities should have these referral mechanisms in place (see Indicator 5), they may not need to use them if they are able to definitively treat all patients in the 3-month reference period. Therefore, a lack of referral from a Comprehensive or Intensive EmONC facility does not necessarily indicate a failure in facility functioning, and so the referral signal function is not required for EmONC classification at Comprehensive and Intensive EmONC levels. ↩︎
Bailey, P. E., van Roosmalen, J., Mola, G., Evans, C., de Bernis, L., & Dao, B. (2017). Assisted vaginal delivery in low and middle income countries: an overview. BJOG: an international journal of obstetrics and gynaecology, 124(9), 1335–1344. ↩︎
Feeley C, Crossland N, Betran AP, Weeks A, Downe S, Kingdon C. Training and expertise in undertaking assisted vaginal delivery (AVD): a mixed methods systematic review of practitioners views and experiences. Reprod Health. 2021;18(1):92. Published 2021 May 5. doi:10.1186/s12978-021-01146-3. ↩︎
Torloni MR, Opiyo N, Altieri E, et al. Interventions to reintroduce or increase assisted vaginal births: a systematic review of the literature. BMJ Open. 2023;13(2):e070640. Published 2023 Feb 14. doi:10.1136/bmjopen-2022-070640. ↩︎
Dominico, S., Kasanga, M., Mwakatundu, N., Chaote, P., Lobis, S., & Bailey, P. E. (2021). Factors related to the practice of vacuum-assisted birth: findings from provider interviews in Kigoma, Tanzania. BMC pregnancy and childbirth, 21(1), 302. ↩︎
Betrán, A. P., Torloni, M. R., Althabe, F., Altieri, E., Arulkumaran, S., Ashraf, F., Bailey, P., Bonet, M., Bucagu, M., Clark, E., Changizi, N., Churchill, R., Dominico, S., Downe, S., Draycott, T., Faye, A., Feeley, C., Geelhoed, D., Gherissi, A., Gholbzouri, K., … Oladapo, O. O. (2023). A research agenda to improve incidence and outcomes of assisted vaginal birth. Bulletin of the World Health Organization, 101(11), 723–729. ↩︎